?? Exciting news from the Metabolic Terrain Institute of Health! ?? As MTIH continues to grow and expand its mission, we are thrilled to announce that Daniele Pasatieri has joined us as our new Executive Director! This leadership transition reflects the next phase of MTIH’s evolution, with a focus on advancing innovative research and expanding access to the metabolic approach. ?? Daniele’s decades of expertise in oncology and her personal journey as a cancer thriver make her an exceptional fit for this role. Dr. Nasha Winters, our Co-Founder and current Executive Director, will remain deeply involved, continuing to guide MTIH’s mission and vision into the future. ? Learn more about Daniele’s inspiring journey and this exciting chapter for MTIH at the link below and lets give her the warmest of welcomes in the comments! ?? https://lnkd.in/e3Sy8ASy
Proven healthcare leader with just enough gumption to believe that brighter days are ahead; we're at a tipping point and restoring metabolic health is key to overall wellness and disease regression.
I am thrilled to join The Metabolic Terrain Institute of Health (MTIH) in the role of Executive Director. My unique blend of professional expertise, personal experience, and passion for integrative health aligns perfectly with MTIH’s mission. This appointment marks an exciting new chapter for MTIH as the organization continues to advance its mission of restoring health through Research, Education, Access, Community, and Hope. My connection to MTIH’s mission is deeply personal. As a current student in MTIH’s Terrain Advocate Program and a cancer thriver, I have experienced firsthand the transformative power of the Metabolic Approach to Cancer. My experience has fortified my belief in addressing root causes, empowering patients, and creating sustainable, life-affirming solutions. This announcement comes at a pivotal time for MTIH. Earlier this year, MTIH opened a state-of-the-art research and development laboratory in Phoenix, Arizona. This milestone expanded the organization’s capabilities in studying therapies that directly target metabolic dysfunction. As MTIH enters the next phases for the lab—focusing on cellular uptake, biomarker discovery, and innovative clinical studies—my extensive experience in laboratory operations, regulated industries, and research strategy will be instrumental in driving these efforts forward. Dr. Nasha Winters, ND, FABNO, MTIH Co-Founder, and former Executive Director, expressed her excitement for this transition. “Daniele’s expertise in laboratory operations and research, coupled with her unwavering commitment to empowering patients, makes her the ideal leader to guide MTIH into this exciting new phase,†Dr. Winters said. “Her personal journey and professional accomplishments embody the very spirit of our mission.†Here's to propelling MTIH into an even brighter future, advancing its transformative work to restore health for those navigating cancer and other metabolic diseases.